Literature DB >> 17182888

An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.

Neil A McDonald1, Christopher M Henstridge, Christopher N Connolly, Andrew J Irving.   

Abstract

In central neurons, the cell-surface distribution of cannabinoid receptor subtype-1 (CB(1)) is highly polarized toward axons and is associated with synaptic terminals, in which it is well-positioned to modulate neurotransmitter release. It has been suggested that high levels of constitutive activity mediate CB(1) receptor axonal targeting, leading to domain-specific endocytosis. We have investigated further the mechanisms that underlie CB(1) receptor axonal polarization in hippocampal neurons and found that constitutive activity is not an essential requirement for this process. We demonstrate that the cell-surface distribution of an N-terminally tagged, fluorescent CB(1) receptor fusion-protein is almost exclusively localized to the axon when expressed in cultured hippocampal neurons. Inhibition of endocytosis by cotransfection with a dominant-negative dynamin-1 (K44A) mutant traps both recombinant and endogenous CB(1) receptors at the somatodendritic cell surface. However, this effect could not be mimicked by inhibiting constitutive activity or receptor activation, either by expressing mutant receptors that lack these properties or by treatment with CB(1) receptor antagonists possessing inverse agonist activity. These data are consistent with a revised model in which domain-specific endocytosis regulates the functional polarization of CB(1) receptors, but this process is distinct from constitutive activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182888     DOI: 10.1124/mol.106.029348

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

Review 1.  Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Authors:  Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.

Authors:  Tanya L Daigle; Christopher S Kearn; Ken Mackie
Journal:  Neuropharmacology       Date:  2007-06-26       Impact factor: 5.250

3.  Constitutive internalization of G protein-coupled receptors and G proteins via clathrin-independent endocytosis.

Authors:  Marco Scarselli; Julie G Donaldson
Journal:  J Biol Chem       Date:  2008-11-25       Impact factor: 5.157

4.  Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.

Authors:  Gábor Turu; Péter Várnai; Pál Gyombolai; László Szidonya; László Offertaler; György Bagdy; George Kunos; László Hunyady
Journal:  J Biol Chem       Date:  2009-04-07       Impact factor: 5.157

5.  Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

Authors:  András Kern; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

Review 6.  Wiring and firing neuronal networks: endocannabinoids take center stage.

Authors:  Tibor Harkany; Ken Mackie; Patrick Doherty
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

7.  Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway.

Authors:  Shi-Bin Cheng; Jeffrey A Quinn; Carl T Graeber; Edward J Filardo
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

8.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

9.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

10.  Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes.

Authors:  Kyle D Osborne; William Lee; Erik B Malarkey; Andrew J Irving; Vladimir Parpura
Journal:  ASN Neuro       Date:  2009-12-08       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.